Home > Products > Pharmaceuticals & Life Science > Pharmaceutical Intermediates > 1-Piperidinecarboxamide, 4-(1,2-dihydro-2-oxo-3-quinolinyl)-N-[(1R)-1-[(7-methyl-1H-indazol-5-yl)methyl]-2-[4-(1-methyl-4-piperidinyl)-1-piperazinyl]-2-oxoethyl]-
1-Piperidinecarboxamide, 4-(1,2-dihydro-2-oxo-3-quinolinyl)-N-[(1R)-1-[(7-methyl-1H-indazol-5-yl)methyl]-2-[4-(1-methyl-4-piperidinyl)-1-piperazinyl]-2-oxoethyl]- structure, CAS 1337918-83-8

1-Piperidinecarboxamide, 4-(1,2-dihydro-2-oxo-3-quinolinyl)-N-[(1R)-1-[(7-methyl-1H-indazol-5-yl)methyl]-2-[4-(1-methyl-4-piperidinyl)-1-piperazinyl]-2-oxoethyl]-

CAS Number1337918-83-8

SynonymsReferences

Molecular FormulaC36H46O3N8

Molecular Weight638.81

Purity

Density1.3±0.1 g/cm3

Boiling Point933.7±65.0 °C at 760 mmHg

Melting Point

Flash Point

Appearance

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-0200326 Purity:
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 1337918-83-8 ] SDS Specification MoL

Chemical & Physical Properties
CAS Number1337918-83-8
Catalog No.2A-0200326
Chinese NameVazegepant
SynonymsReferences
Molecular FormulaC36H46O3N8
Molecular Weight638.81
Density1.3±0.1 g/cm3
Boiling Point933.7±65.0 °C at 760 mmHg
ApplicationVazegepant is the first intranasal CGRP receptor antagonist used in acute studies of migraine [1][2].
MDL NumberMFCD27938555
MSDSmsds/202243_1_1337918_83_8.pdf
Transport InfoProduct name: N-{(2R)-3-(7-Methyl-1H-indazol-5-yl)-1-[4-(1-methyl-4-piperidinyl)-1-piperazinyl]-1-oxo-2-propanyl}-4-(2-oxo-1,2-dihydro-3-quinolinyl)-1-piperidinecarboxamide
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA